Zentek Ltd. Common Stock (ZTEK) is a publicly traded Healthcare sector company. As of October 5, 2026, ZTEK trades at $0.49 with a market cap of $62.30M and a P/E ratio of 0.00. ZTEK moved -3.82% today. Year to date, ZTEK is -34.84%; over the trailing twelve months it is -45.50%. Its 52-week range spans $0.37 to $1.84. Rallies surfaces ZTEK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Zentek SVP of strategy and business development Ryan Shacklock departs: Zentek said Ryan Shacklock exited as senior vice president of strategy and business development effective Oct. 5, 2026, and named Angela Lomets vice president of commercialization for ZenGUARD and Morgan Knowles to lead investor relations and capital markets communications.
| Metric | Value |
|---|---|
| Price | $0.49 |
| Market Cap | $62.30M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.84 |
| 52-Week Low | $0.37 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
ZTEK analyst coverage data. Average price target: $0.00.